Reyoung Pharmaceutical Co., Ltd
서양제약(주)
서양약품유한회사(Ruiyang Pharmaceutical Co., Ltd.)는 R&D, 생산, 판매를 통합한 종합 현대제약회사입니다. 현재 직원 수는 5,000명이 넘고 부지면적은 120만 평방미터에 이릅니다. 국가첨단기술기업, 바이오의약품 산업화를 위한 국가기반기업, 국가기술혁신시범기업이다. 회사의 주요 사업 수익은 수년 동안 전국 제약 산업 상위 100대 기업 중 상위 50위 안에 들었습니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Shandong, China
- Website
- https://www.reyoung.cn
- Categories
- 의약품 제조, 보충제 및 웰니스
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- registered-manufacturer (green), checked 2026-08-21 Superintendencia de Regulacion Sanitaria de El Salvador, listado de productos farmaceuticos con registro sanitario vigente
- gmp-certified (green), effective since 2025-02-22 EudraGMDP, EU register of GMP certificates (EMA)
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)